Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jie-Hao Xu, Jinhyuk Lee, Shang-Jun Yin, Wei Wang & Yong-Doo Park. (2023) Inhibitory effect of acarbose on tyrosinase: application of molecular dynamics integrating inhibition kinetics. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-12.
Read now
Read now
Priyanka Sharma, Tushar Joshi, Tanuja Joshi, Subhash Chandra & Sushma Tamta. (2021) Molecular dynamics simulation for screening phytochemicals as α-amylase inhibitors from medicinal plants. Journal of Biomolecular Structure and Dynamics 39:17, pages 6524-6538.
Read now
Read now
Ranjeet Prasad Dash, R. Jayachandra Babu & Nuggehally R. Srinivas. (2018) Reappraisal and perspectives of clinical drug–drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 diabetes mellitus. Xenobiotica 48:1, pages 89-108.
Read now
Read now
Shashank R Joshi, Ambady Ramachandran, Manoj Chadha, Sudip Chatterjee, Rahul Rathod & Sanjay Kalra. (2014) Acarbose plus metformin fixed-dose combination in the management of type 2 diabetes. Expert Opinion on Pharmacotherapy 15:11, pages 1611-1620.
Read now
Read now
Violet Kasabri, Fatma U. Afifi & Imad Hamdan. (2011) Evaluation of the acute antihyperglycemic effects of four selected indigenous plants from Jordan used in traditional medicine. Pharmaceutical Biology 49:7, pages 687-695.
Read now
Read now
Giuseppe Derosa, Sibilla A. T. Salvadeo, Angela D’Angelo, Ilaria Ferrari, Roberto Mereu, Ilaria Palumbo, Pamela Maffioli, Sabrina Randazzo & Arrigo F. G. Cicero. (2009) Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial. Current Medical Research and Opinion 25:3, pages 607-615.
Read now
Read now
Articles from other publishers (52)
Miłosz Nesterowicz, Kamil Klaudiusz Lauko, Karolina Dańkowska, Daria Trocka, Małgorzata Żendzian-Piotrowska, Jerzy Robert Ładny, Anna Zalewska & Mateusz Maciejczyk. (2023) Preliminary evaluation of the antiglycoxidant activity of verapamil using various in vitro and in silico biochemical/biophysical methods. Frontiers in Pharmacology 14.
Crossref
Crossref
Abdur Rehman Sheikh, Anam Arif & Md. Musawwer Khan. (2023) Aryl glyoxal: a prime synthetic equivalent for multicomponent reactions in the designing of oxygen heterocycles. RSC Advances 13:17, pages 11652-11684.
Crossref
Crossref
Karim Almahayni, Malte Spiekermann, Antonio Fiore, Guoqiang Yu, Kayvon Pedram & Leonhard Möckl. (2022) Small molecule inhibitors of mammalian glycosylation. Matrix Biology Plus 16, pages 100108.
Crossref
Crossref
Sabbir Ahmed, Md Ali, Rumana Ruma, Shafi Mahmud, Gobindo Paul, Md Saleh, Mohammed Alshahrani, Ahmad Obaidullah, Sudhangshu Biswas, Md Rahman, Md Rahman & Md Islam. (2022) Molecular Docking and Dynamics Simulation of Natural Compounds from Betel Leaves (Piper betle L.) for Investigating the Potential Inhibition of Alpha-Amylase and Alpha-Glucosidase of Type 2 Diabetes. Molecules 27:14, pages 4526.
Crossref
Crossref
Yi Wang, Xinlei Xu, Jianle Chen, Xingqian Ye, Haibo Pan & Shiguo Chen. (2022)
Improving Regulation of Polymeric Proanthocyanidins and Tea Polyphenols against Postprandial Hyperglycemia
via
Acid-Catalyzed Transformation
. Journal of Agricultural and Food Chemistry 70:16, pages 5218-5227.
Crossref
Crossref
Inas Y. Younis, Amira R. Khattab, Nabil M. Selim, Mansour Sobeh, Seham S. Elhawary & Mahitab H. El Bishbishy. (2022) Metabolomics-based profiling of 4 avocado varieties using HPLC–MS/MS and GC/MS and evaluation of their antidiabetic activity. Scientific Reports 12:1.
Crossref
Crossref
Qi Dong, Na Hu, Huilan Yue, Honglun Wang & Jinliang Ku. (2021) Identification of α-glucosidase inhibitors from the bran of Chenopodium quinoa Willd. by surface plasmon resonance coupled with ultra-performance liquid chromatography and quadrupole-time-of-flight-mass spectrometry. Journal of Chromatography B 1181, pages 122919.
Crossref
Crossref
Ramesh S. Gani, Avinash K. Kudva, Karabasanagouda Timanagouda, Raghuveer, Salma Begum Hussain Mujawar, Shrinivas D. Joshi & Shamprasad Varija Raghu. (2021) Synthesis of novel 5-(2,5-bis(2,2,2-trifluoroethoxy)phenyl)-1,3,4-oxadiazole-2-thiol derivatives as potential glucosidase inhibitors. Bioorganic Chemistry 114, pages 105046.
Crossref
Crossref
L. A. Baltina, T. A. Sapozhnikova, S. F. Gabdrakhmanova, N. S. Makara, R. Yu. Khisamutdinova, L. A. Baltina, Jr, S. F. Petrova, D. R. Saifullina & R. M. Kondratenko. (2021) Hypoglycemic Activity of Glycyrrhizic Acid and Some of its Derivatives in the Alloxan Diabetes Model in Rats. Pharmaceutical Chemistry Journal.
Crossref
Crossref
Wei Ji, Shaomei Yang, Wenyu Zhang, Zhongliang Sun, Qing Wen & Kun He. (2021) Pharmacodynamic comparison of acarbose tablets in Chinese healthy volunteers under chewing and swallowing conditions. Journal of Clinical Pharmacy and Therapeutics 46:3, pages 814-819.
Crossref
Crossref
Rafaella R. Costa, João A. Oliveira-da-Silva, Thiago A. R. Reis, Grasiele S. V. Tavares, Débora V. C. Mendonça, Camila S. Freitas, Daniela P. Lage, Vívian T. Martins, Luciana M. R. Antinarelli, Amanda S. Machado, Raquel S. Bandeira, Fernanda Ludolf, Thaís T. O. Santos, Rory C. F. Brito, Maria V. Humbert, Daniel Menezes-Souza, Mariana C. Duarte, Miguel A. Chávez-Fumagalli, Bruno M. Roatt, Elaine S. Coimbra & Eduardo A. F. Coelho. (2021) Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis. Medical Microbiology and Immunology 210:2-3, pages 133-147.
Crossref
Crossref
Suxiang ChenNabayet SbuhRakesh N. Veedu. (2021) Antisense Oligonucleotides as Potential Therapeutics for Type 2 Diabetes. Nucleic Acid Therapeutics 31:1, pages 39-57.
Crossref
Crossref
Alwin M. Hartman, Varsha R. Jumde, Walid A. M. Elgaher, Evelien M. Te Poele, Lubbert Dijkhuizen & Anna K. H. Hirsch. (2020) Potential Dental Biofilm Inhibitors: Dynamic Combinatorial Chemistry Affords Sugar‐Based Molecules that Target Bacterial Glucosyltransferase. ChemMedChem 16:1, pages 113-123.
Crossref
Crossref
Bing Zhao, Feifei Wu, Xue Han, Wenwei Zhou, Qiaojuan Shi & Hao Wang. (2020) Protective effects of acarbose against insulitis in multiple low-dose streptozotocin-induced diabetic mice. Life Sciences 263, pages 118490.
Crossref
Crossref
Changlin Li, Jian Kuang, Yishen Zhao, Hui Sun & Haixia Guan. (2020) Effect of type 2 diabetes and antihyperglycemic drug therapy on signs of tumor invasion in papillary thyroid cancer. Endocrine 69:1, pages 92-99.
Crossref
Crossref
Lingshu Zhang, Pingfang Song, Xiaowei Zhang, Christina Metea, Matthew Schleisman, Lisa Karstens, Eric Leung, Jun Zhang, Qiang Xu, Yi Liu, Mark Asquith & Cong-Qiu Chu. (2020) Alpha-Glucosidase Inhibitors Alter Gut Microbiota and Ameliorate Collagen-Induced Arthritis. Frontiers in Pharmacology 10.
Crossref
Crossref
Sherry G. Dodds, Manish Parihar, Martin Javors, Jia Nie, Nicolas Musi, Zelton Dave Sharp & Paul Hasty. (2020)
Acarbose improved survival for
Apc
+/Min
mice
. Aging Cell 19:2.
Crossref
Crossref
Tae Jung Oh, Jae Myung YuKyung Wan MinHyun Shik SonMoon Kyu LeeKun Ho YoonYoung Duk SongJoong Yeol ParkIn Kyung JeongBong Soo ChaYong Seong KimSei Hyun BaikIn Joo KimDoo Man KimSung Rae KimKwan Woo LeeJeong Hyung ParkIn Kyu LeeTae Sun ParkSung Hee Choi & Sung Woo Park. (2019) Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial. Diabetes & Metabolism Journal 43:3, pages 276.
Crossref
Crossref
Andrew J. Krentz & Gerardo Rodriguez-Araujo. (2017) Cardiovascular Outcome Trials of Diabetes and Obesity Drugs: Implications for Conditional Approval and Early Phase Clinical Development. Pharmaceutical Medicine 31:6, pages 399-421.
Crossref
Crossref
Andrew J. Krentz. (2016) Hypertension in type 2 diabetes: impact of glucose-lowering medications. Cardiovascular Endocrinology 5:4, pages 137-143.
Crossref
Crossref
William T. Cefalu, John B. Buse, Jaakko Tuomilehto, G. Alexander Fleming, Ele Ferrannini, Hertzel C. Gerstein, Peter H. Bennett, Ambady Ramachandran, Itamar Raz, Julio Rosenstock & Steven E. Kahn. (2016) Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum. Diabetes Care 39:7, pages 1186-1201.
Crossref
Crossref
Alexey Moskalev, Elizaveta Chernyagina, Vasily Tsvetkov, Alexander Fedintsev, Mikhail Shaposhnikov, Vyacheslav Krut'ko, Alex Zhavoronkov & Brian K. Kennedy. (2016) Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic. Aging Cell 15:3, pages 407-415.
Crossref
Crossref
Pia V Röder, Bingbing Wu, Yixian Liu & Weiping Han. (2016) Pancreatic regulation of glucose homeostasis. Experimental & Molecular Medicine 48:3, pages e219-e219.
Crossref
Crossref
Kenneth S. Polonsky & Charles F. Burant. 2016. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology
1385
1450
.
Chien-Hung Jhong, Jirawat Riyaphan, Shih-Hung Lin, Yi-Chen Chia & Ching-Feng Weng. (2015)
Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking
in silico
. BioFactors 41:4, pages 242-251.
Crossref
Crossref
Wen-Wen Yan, Gui-Hai Chen, Fang Wang, Jing-Jing Tong & Fei Tao. (2015) Long-term acarbose administration alleviating the impairment of spatial learning and memory in the SAMP8 mice was associated with alleviated reduction of insulin system and acetylated H4K8. Brain Research 1603, pages 22-31.
Crossref
Crossref
Johann Trutz, Aurel Babeș & Katalin Babeș. (2015) The Importance of the Treatment Strategy Changes in the Long-Term Evolution of Type 2 Diabetic Patients with Sub-Optimal Glycaemic Control After Acute Coronary Syndrome. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 22:1.
Crossref
Crossref
Yien Chiong & Carmella Evans-Molina. 2015. PanVascular Medicine. PanVascular Medicine
1541
1593
.
Chris R. Triggle & Hong Ding. (2014) Cardiovascular impact of drugs used in the treatment of diabetes. Therapeutic Advances in Chronic Disease 5:6, pages 245-268.
Crossref
Crossref
M.?. Prieto, J.M. Comas Samper, C. Escobar Cervantes & V. Gasull Molinera. (2014) Seguridad cardiovascular de los antidiab?ticos no insul?nicos. Posicionamiento cient?fico SEMERGEN. SEMERGEN - Medicina de Familia 40:5, pages 261-273.
Crossref
Crossref
Eberhard Standl, Michael J Theodorakis, Michael Erbach, Oliver Schnell & Jaakko Tuomilehto. (2014) On the potential of acarbose to reduce cardiovascular disease. Cardiovascular Diabetology 13:1, pages 81.
Crossref
Crossref
Yien Chiong & Carmella Evans-Molina. 2013. PanVascular Medicine. PanVascular Medicine
1
65
.
Ankur Jindal, Mariana Garcia-Touza, Nidhi Jindal, Adam Whaley-Connell & James R. Sowers. (2013) Diabetic Kidney Disease and the Cardiorenal Syndrome. Endocrinology and Metabolism Clinics of North America 42:4, pages 789-808.
Crossref
Crossref
Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L. Peters, Apostolos Tsapas, Richard Wender & David R. Matthews. (2012) Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Spectrum 25:3, pages 154-171.
Crossref
Crossref
Eberhard Standl & Oliver Schnell. (2012) Alpha-glucosidase inhibitors 2012 – cardiovascular considerations and trial evaluation. Diabetes and Vascular Disease Research 9:3, pages 163-169.
Crossref
Crossref
Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaela Diamant, Ele FerranniniMichael Nauck, Anne L. Peters, Apostolos Tsapas, Richard Wender & David R. Matthews. (2012) Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Diabetes Care 35:6, pages 1364-1379.
Crossref
Crossref
. (2012) Prise en charge de l’hyperglycémie chez le patient diabétique de type 2 : une stratégie centrée sur le patient. Médecine des Maladies Métaboliques 6, pages III-XXV.
Crossref
Crossref
S. E. Inzucchi, R. M. Bergenstal, J. B. Buse, M. Diamant, E. Ferrannini, M. Nauck, A. L. Peters, A. Tsapas, R. Wender & D. R. Matthews. (2012) Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 55:6, pages 1577-1596.
Crossref
Crossref
Chunlin Li, Yi-Jen Hung, Karim Qamruddin, Mohamed Fahmy Abdel Aziz, Herbert Stein & Birgit Schmidt. (2011) International noninterventional study of acarbose treatment in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 92:1, pages 57-64.
Crossref
Crossref
Masayuki Isaji. (2011) SGLT2 inhibitors: molecular design and potential differences in effect. Kidney International 79, pages S14-S19.
Crossref
Crossref
Toshio HOSAKA, Yoshitaka NII, Hiroyuki TOMOTAKE, Takahiro ITO, Aya TAMANAHA, Yukiko YAMASAKA, Sayaka SASAGA, Kazuhiro EDAZAWA, Rie TSUTSUMI, Emi SHUTO, Naoki OKAHISA, Shinya IWATA & Tohru SAKAI. (2011) Extracts of Common Buckwheat Bran Prevent Sucrose Digestion. Journal of Nutritional Science and Vitaminology 57:6, pages 441-445.
Crossref
Crossref
John B. Buse, Kenneth S. Polonsky & Charles F. Burant. 2011. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology
1371
1435
.
John O. Nyalala, Shaoke Luo, Danielle N. Campbell, Aliza T. Brown & Mohammed M. Moursi. (2010) The Effects of Acarbose Treatment on Intimal Hyperplasia in a Rat Carotid Endarterectomy Model of Diet-Induced Insulin Resistance. Vascular and Endovascular Surgery 44:7, pages 560-567.
Crossref
Crossref
G. Derosa, R. Mereu, A. D’Angelo, S. A. Salvadeo, I. Ferrari, E. Fogari, A. Gravina, I. Palumbo, P. Maffioli, S. Randazzo & A. F. G. Cicero. (2010) ORIGINAL ARTICLE: Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin. Journal of Clinical Pharmacy and Therapeutics 35:5, pages 565-579.
Crossref
Crossref
Ogusa Kamiyama, Fujiko Sanae, Kyoko Ikeda, Yasuhiko Higashi, Yasuhiro Minami, Naoki Asano, Isao Adachi & Atsushi Kato. (2010) In vitro inhibition of α-glucosidases and glycogen phosphorylase by catechin gallates in green tea. Food Chemistry 122:4, pages 1061-1066.
Crossref
Crossref
E. I. Krasilnikova, Y. V. Blagosklonnaya, E. I. Baranova, E. N. Grineva, A. A. Bystrova, I. A. Ryumina, A. R. Volkova & T. L. Karonova. (2009) THE ROLE OF ACARBOSE IN THE TREATMENT AND PREVENTION OF DIABETES MELLITUS TYPE 2: NEW OPPORTUNITIES IN CARDIOVASCULAR RISK DECREASE. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 15:6, pages 640-647.
Crossref
Crossref
Giuseppe Derosa, Angela D'Angelo, Sibilla A.T. Salvadeo, Ilaria Ferrari, Elena Fogari, Alessia Gravina, Roberto Mereu, Ilaria Palumbo, Pamela Maffioli, Sabrina Randazzo & Arrigo F.G. Cicero. (2009) Modulation of adipokines and vascular remodelling markers during OGTT with acarbose or pioglitazone treatment. Biomedicine & Pharmacotherapy 63:10, pages 723-733.
Crossref
Crossref
Giuseppe Derosa, Pamela Maffioli, Sibilla A.T. Salvadeo, Ilaria Ferrari, Alessia Gravina, Roberto Mereu, Ilaria Palumbo, Angela D'Angelo & Arrigo F.G. Cicero. (2009) Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study. Metabolism 58:8, pages 1059-1066.
Crossref
Crossref
Wim van Biesen, Steven Van Laecke & Raymond Vanholder. (2009) Treatment of type 2 diabetes in chronic kidney disease: meekly follow the herd or call to arms?. Nephrology Dialysis Transplantation 24:7, pages 2286-2287.
Crossref
Crossref
P. Prabhakar Reddy, Ashok K. Tiwari, R. Ranga Rao, K. Madhusudhana, V. Rama Subba Rao, Amtul Z. Ali, K. Suresh Babu & J. Madhusudana Rao. (2009) New Labdane diterpenes as intestinal ?-glucosidase inhibitor from antihyperglycemic extract of Hedychium spicatum (Ham. Ex Smith) rhizomes. Bioorganic & Medicinal Chemistry Letters 19:9, pages 2562-2565.
Crossref
Crossref
D.B. McNamara, S.N. Murthy, A.N. Fonseca, C.V. Desouza, P.J. Kadowitz & V.A. Fonseca. (2009) Animal models of catheter-induced intimal hyperplasia in type 1 and type 2 diabetes and the effects of pharmacologic intervention. Canadian Journal of Physiology and Pharmacology 87:1, pages 37-50.
Crossref
Crossref
Srividya Kidambi & Shailendra B. Patel. (2008) Diabetes Mellitus. The Journal of the American Dental Association 139, pages 8S-18S.
Crossref
Crossref